Lineage Cell Therapeutics
LCTX
#8906
Rank
NZ$0.35 B
Marketcap
NZ$1.41
Share price
-5.87%
Change (1 day)
-54.46%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2026 (TTM): NZ-$0.45

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.49. In 2019 the company made an earnings per share (EPS) of NZ-$0.07312 an increase over its 2018 EPS that were of NZ-$0.64.

EPS history for Lineage Cell Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.45
2019NZ-$0.07312-88.57%
2018NZ-$0.64
2016NZ$0.58
2014NZ-$1.02
2012NZ-$0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA